FDA Inspection 1203347 — Siegfried Hameln GmbH

Siegfried Hameln GmbH — FEI 3002807877

The FDA completed an inspection of Siegfried Hameln GmbH on September 1, 2022 in Hameln. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hameln (Germany)

Additional Details

Mutual Recognition Agreement (MRA)